• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾脏病学中的虚拟护理:使用重置肾脏健康模型对结局进行的深入回顾性分析。

Virtual Care in Nephrology: An In-Depth Retrospective Analysis of Outcomes Using the Reset Kidney Health Model.

作者信息

Fritz Benjamin A

机构信息

Reset Kidney Health, New York, NY 10001, USA.

出版信息

J Clin Med. 2023 Dec 22;13(1):66. doi: 10.3390/jcm13010066.

DOI:10.3390/jcm13010066
PMID:38202073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10779835/
Abstract

The advent of virtual healthcare has reshaped patient management paradigms across various medical domains. This analysis examines the potential effectiveness of treating chronic kidney disease (CKD) using Reset Kidney Health's virtual, multidisciplinary, and integrated care approach. The pilot study concentrated on evaluating the impact of this care model on the estimated Glomerular Filtration Rate (eGFR) of CKD patients over an eight-month period. The analyses showed that a majority of patients managed with the Reset Kidney Health Model experienced stability or improvements in their kidney function, as measured by eGFR. While this pilot study has several limitations, these early results suggest the potential benefits of digital healthcare innovations in chronic disease management and provide an argument for the broader integration of virtual care strategies in healthcare systems. These initial findings could lay the groundwork for further research into effectively integrating digital healthcare in chronic disease management.

摘要

虚拟医疗的出现重塑了各个医学领域的患者管理模式。本分析探讨了采用“重置肾脏健康”的虚拟、多学科综合护理方法治疗慢性肾脏病(CKD)的潜在效果。该试点研究专注于评估这种护理模式在八个月期间对CKD患者估算肾小球滤过率(eGFR)的影响。分析表明,采用“重置肾脏健康”模式管理的大多数患者,其肾功能(通过eGFR衡量)保持稳定或有所改善。尽管这项试点研究存在若干局限性,但这些早期结果表明了数字医疗创新在慢性病管理中的潜在益处,并为在医疗系统中更广泛地整合虚拟护理策略提供了依据。这些初步发现可为进一步研究如何有效将数字医疗整合到慢性病管理中奠定基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e235/10779835/182eb0cdd054/jcm-13-00066-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e235/10779835/7f01907df724/jcm-13-00066-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e235/10779835/182eb0cdd054/jcm-13-00066-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e235/10779835/7f01907df724/jcm-13-00066-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e235/10779835/182eb0cdd054/jcm-13-00066-g002.jpg

相似文献

1
Virtual Care in Nephrology: An In-Depth Retrospective Analysis of Outcomes Using the Reset Kidney Health Model.肾脏病学中的虚拟护理:使用重置肾脏健康模型对结局进行的深入回顾性分析。
J Clin Med. 2023 Dec 22;13(1):66. doi: 10.3390/jcm13010066.
2
Nephrology co-management versus primary care solo management for early chronic kidney disease: a retrospective cross-sectional analysis.早期慢性肾脏病的肾脏病共同管理与初级保健单独管理:一项回顾性横断面分析。
BMC Nephrol. 2015 Oct 12;16:162. doi: 10.1186/s12882-015-0154-x.
3
Integrating Risk-Based Care for Patients With Chronic Kidney Disease in the Community: Study Protocol for a Cluster Randomized Trial.整合社区慢性肾脏病患者的基于风险的护理:一项整群随机试验的研究方案
Can J Kidney Health Dis. 2019 May 29;6:2054358119841611. doi: 10.1177/2054358119841611. eCollection 2019.
4
Development of an electronic health record-based chronic kidney disease registry to promote population health management.基于电子健康记录的慢性肾脏病登记系统的开发,以促进人群健康管理。
BMC Nephrol. 2019 Mar 1;20(1):72. doi: 10.1186/s12882-019-1260-y.
5
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.
6
Findings of Sodium-Glucose Cotransporter-2 Inhibitor Kidney Outcome Trials Applied to a Canadian Chronic Kidney Disease Population: A Retrospective Cohort Study.钠-葡萄糖协同转运蛋白2抑制剂肾脏结局试验结果应用于加拿大慢性肾脏病患者群体:一项回顾性队列研究
Can J Kidney Health Dis. 2022 Dec 20;9:20543581221145068. doi: 10.1177/20543581221145068. eCollection 2022.
7
Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease.血管紧张素转换酶抑制剂与血管紧张素II受体阻滞剂作为常染色体显性多囊肾病一线治疗的成本效益
J Med Econ. 2017 Jul;20(7):715-722. doi: 10.1080/13696998.2017.1311266. Epub 2017 Apr 13.
8
Screening and Recognition of Chronic Kidney Disease in VA Health Care System Primary Care Clinics.VA 医疗保健系统初级保健诊所的慢性肾脏病筛查和识别。
Kidney360. 2020 Jul 9;1(9):904-915. doi: 10.34067/KID.0000532020. eCollection 2020 Sep 24.
9
Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes.在2型糖尿病患者慢性肾病早期,同时进行尿白蛋白与肌酐比值检测和估计肾小球滤过率检测的估计健康经济影响。
J Med Econ. 2023 Jan-Dec;26(1):935-943. doi: 10.1080/13696998.2023.2235922.
10
Benefits of SGLT2 inhibitors combining with renin-angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis.SGLT2 抑制剂联合肾素-血管紧张素系统阻滞剂对慢性肾脏病患者心血管结局的影响:系统评价和荟萃分析。
Med Clin (Barc). 2022 Jul 22;159(2):65-72. doi: 10.1016/j.medcli.2021.09.031. Epub 2021 Dec 3.

本文引用的文献

1
Chronic Kidney Disease: Role of Diet for a Reduction in the Severity of the Disease.慢性肾脏病:饮食在减轻疾病严重程度方面的作用。
Nutrients. 2021 Sep 19;13(9):3277. doi: 10.3390/nu13093277.
2
GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials.GFR 斜率作为临床试验中肾脏疾病进展的替代终点:一项随机对照试验治疗效果的荟萃分析。
J Am Soc Nephrol. 2019 Sep;30(9):1735-1745. doi: 10.1681/ASN.2019010007. Epub 2019 Jul 10.
3
Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease.
慢性肾病患者测量和估算的肾小球滤过率的生物学变异
Kidney Int. 2019 Aug;96(2):429-435. doi: 10.1016/j.kint.2019.02.021. Epub 2019 Mar 7.
4
Risk Factors for Unplanned Dialysis Initiation: A Systematic Review of the Literature.非计划开始透析的危险因素:文献系统评价
Can J Kidney Health Dis. 2019 Mar 13;6:2054358119831684. doi: 10.1177/2054358119831684. eCollection 2019.
5
All-cause costs increase exponentially with increased chronic kidney disease stage.全因费用随慢性肾脏病阶段的增加呈指数级增长。
Am J Manag Care. 2017 Jun;23(10 Suppl):S163-S172.
6
Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USA.美国终末期肾病患者终末期肾病前的肾脏病护理及预后
Clin Kidney J. 2015 Dec;8(6):772-80. doi: 10.1093/ckj/sfv103. Epub 2015 Nov 3.
7
Chronic kidney disease: global dimension and perspectives.慢性肾脏病:全球维度与展望。
Lancet. 2013 Jul 20;382(9888):260-72. doi: 10.1016/S0140-6736(13)60687-X. Epub 2013 May 31.
8
Access to health care among adults evaluated for CKD: findings from the Kidney Early Evaluation Program (KEEP).慢性肾脏病评估成人的医疗保健获取情况:肾脏早期评估计划(KEEP)的研究结果。
Am J Kidney Dis. 2012 Mar;59(3 Suppl 2):S5-15. doi: 10.1053/j.ajkd.2011.10.043.
9
Slowing the progression of chronic renal failure: economic benefits and patients' perspectives.延缓慢性肾衰竭的进展:经济效益与患者视角
Am J Kidney Dis. 2002 Apr;39(4):721-9. doi: 10.1053/ajkd.2002.31990.